Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Clinical and laboratory data in heterozygous factor V Leiden mutation positive versus negative patients with TIA and minor stroke.

Lalouschek W, Suess E, Aull S, Schnider P, Uhl F, Zeiler K, Pabinger-Fasching I.

Stroke. 1995 Oct;26(10):1963-4. No abstract available.

PMID:
7570761
2.

C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study.

Lalouschek W, Aull S, Serles W, Schnider P, Mannhalter C, Pabinger-Fasching I, Deecke L, Zeiler K.

Thromb Res. 1999 Jan 15;93(2):61-9.

PMID:
9950259
3.

Factor V Leiden mutation and completed stroke.

Catto A, Carter A, Grant PJ.

Stroke. 1996 Mar;27(3):573. No abstract available.

PMID:
8610336
4.

Activated protein C resistance due to a factor V mutation associated with familial ischemic stroke.

De Lucia D, Nina P, Papa ML, Belli A, Conte M, Renis V, Di Mauro C, Masi S, Franco A, Schisano G.

J Neurosurg Sci. 1997 Dec;41(4):373-8.

PMID:
9555645
5.

[Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family].

Moia M, La Spina I, Padalino R, Carpenedo M.

Ann Ital Med Int. 1996 Jan-Mar;11(1):17-9. Italian.

PMID:
8645525
6.

677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke.

Lalouschek W, Aull S, Korninger L, Mannhalter C, Pabinger-Fasching I, Schmid RW, Schnider P, Zeiler K.

J Neurol Sci. 1998 Mar 5;155(2):156-62.

PMID:
9562260
7.

Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.

Fisher M, Fernandez JA, Ameriso SF, Xie D, Gruber A, Paganini-Hill A, Griffin JH.

Stroke. 1996 Jul;27(7):1163-6.

8.
9.

Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.

Lalouschek W, Schillinger M, Hsieh K, Endler G, Tentschert S, Lang W, Cheng S, Mannhalter C.

Stroke. 2005 Jul;36(7):1405-9.

10.

Stroke in a neonate heterozygous for factor V Leiden.

Varelas PN, Sleight BJ, Rinder HM, Sze G, Ment LR.

Pediatr Neurol. 1998 Mar;18(3):262-4.

PMID:
9568926
11.

The prothrombin G20210A mutation and factor V Leiden mutation in patients with cerebrovascular disease.

Lalouschek W, Aull S, Series W, Zeiler K, Mannhalter C.

Blood. 1998 Jul 15;92(2):704-5. No abstract available.

12.

Factor V Leiden mutation in cerebrovascular disease.

Buyru N, Altinisik J, Somay G, Ulutin T.

Clin Appl Thromb Hemost. 2005 Jul;11(3):339-42.

PMID:
16015421
13.

Factor V Leiden: a case study and review.

Slusher KB.

Dimens Crit Care Nurs. 2010 Jan-Feb;29(1):6-10. doi: 10.1097/DCC.0b013e3181be4985. Review.

PMID:
20010186
14.

Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.

Födinger M, Mannhalter C, Pabinger I, Koizar D, Rintelen C, Hörl WH, Sunder-Plassmann G.

Nephrol Dial Transplant. 1996 Apr;11(4):668-72.

15.

Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.

Rahimi Z, Vaisi-Raygani A, Nagel RL, Muniz A.

J Thromb Thrombolysis. 2008 Jun;25(3):288-92.

PMID:
17619828
16.

The Leiden mutation of coagulation factor V in Hungarian SLE patients.

Regéczy N, Lakos G, Balogh I, Ajzner E, Kiss E, Szegedi G.

Clin Appl Thromb Hemost. 2000 Jan;6(1):41-5.

PMID:
10726048
17.

Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients.

Lüdemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, Assmann G, Ringelstein EB.

Stroke. 1998 Dec;29(12):2507-10.

18.

Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study.

Cushman M, Rosendaal FR, Psaty BM, Cook EF, Valliere J, Kuller LH, Tracy RP.

Thromb Haemost. 1998 May;79(5):912-5.

PMID:
9609219
19.

Factor V Leiden mutation in a case with ischemic stroke: which relationship? A case report.

Orlandi G, Pellegrinetti A, Fioretti C, Martini A, Murri L.

Angiology. 1998 Jan;49(1):79-82.

PMID:
9456169
20.

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.

Items per page

Supplemental Content

Support Center